Comparing new scores for liver cirrhosis
Part of Digestive system clinical trials.
This trial compares new scoring tools to predict outcomes in people with liver cirrhosis who are hospitalized for sudden worsening (like fluid buildup, confusion, or bleeding). It aims to find which score works best to guide care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Diagnosed with liver cirrhosis (by ultrasound or fibroscan)
- Currently in the hospital for a sudden complication like fluid in the belly (ascites), confusion (hepatic encephalopathy), bleeding from veins in the throat (variceal bleeding), or a belly infection (SBP)
- No prior liver transplant
- Not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at new blood markers to better predict recovery in patients hospitalized for complications of cirrhosis (like fluid buildup, confusion, or bleeding). You may qualify if you were recently hospitalized for these issues and are expected to go home soon.
This trial is testing new scoring systems to better predict how patients with acute-on-chronic liver failure will do. It may help doctors make more informed treatment decisions for people with this serious liver condition.
This study uses different scoring systems to predict how well patients with cirrhosis will do while waiting for a liver transplant. It helps doctors understand which patients are most likely to benefit from the transplant.
This trial tests whether using remote monitoring (checking your health from home) can help manage liver cirrhosis. It aims to make care easier and catch problems early without extra hospital visits.
This study looks at how well two factors—a score called ALBI (a measure of liver function) and muscle wasting (sarcopenia)—can predict outcomes in people with cirrhosis who are hospitalized for confusion from liver disease. The goal is to see if these markers can help doctors better understand recovery and risks.
This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.